The retinoid X receptor and its ligands: Versatile regulators of metabolic function, cell differentiation and cell death

Journal of Biological Regulators and Homeostatic Agents

Volumn 17, Issue 1, 2003, Pages 29-45

  Ahuja, H S ^a   Szanto, A ^b   Nagy, L ^b   Davies, Peter J A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Apoptosis; Cholesterol metabolism; Glucose metabolism; Lipid metabolism; Myeloid cell differentiation; Retinoid X Receptor; Structural studies

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CELL NUCLEUS RECEPTOR; CHOLESTEROL; FATTY ACID; GLUCOSE; LIGAND; LIPID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RETINOID X RECEPTOR;

ATHEROSCLEROSIS; BINDING AFFINITY; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLESTEROL METABOLISM; DRUG MECHANISM; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; KNOCKOUT GENE; LIGAND BINDING; METABOLIC DISORDER; METABOLISM; MORPHOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; RECEPTOR BINDING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 0038147081     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. Sporn M, Roberts A, Goodman D. The retinoids: biology, chemistry and medicine (ed 2nd). New York: Raven Press; 1994.
2. Petkovich M, Brand NJ, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-50.
3. Giguere V, Ong ES, Segui P, Evans RM. Identification of a receptor for the morphogen retinoic acid. Nature 1987; 330: 624-9.
4. Mangelsdorf DJ, Ong ES, Dyck JA, Evans RM. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature 1990; 345: 224-9.
5. Heyman RA, Mangelsdorf DJ, Dyck JA, Stein RB, Eichele G, Evans RM, Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992; 68: 397-406.
6. Levin AA, Sturzenbecker LJ, Kazmer S, et al. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature 1992; 355: 359-61.
7. Beard RL, Colon DF, Song TK, Davies PJ, Kochhar DM, Chandraratna RA. Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid. J Med Chem 1996; 39: 3556-63.
8. Boehm MF, Zhang L, Zhi L, et al. Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells. J Med Chem 1995; 38: 3146-55.
9. Lehmann JM, Jong L, Fanjul A, et al. Retinoids selective for retinoid X receptor response pathways. Science 1992; 258: 1944-6.
10. Mukherjee R, Davies PJ, Crombie DL, et al. Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists. Nature 1997; 386: 407-10.
11. Mangelsdorf DJ, Kliewer SA, Kakizuka A, Umesono K, Evans RM. Retinoid receptors. Recent Prog Horm Res 1993; 48: 99-121.
12. Allenby G, Bocquel MT, Saunders M, et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 1993; 90: 30-4.
13. Escriva H, Delaunay F, Laudet V. Ligand binding and nuclear receptor evolution. Bioessays 2000; 22: 717-27.
14. Owen GI, Zelent A. Origins and evolutionary diversification of the nuclear receptor superfamily. Cell Mol Life Sci 2000; 57: 809-27.
15. Escriva H, Safi R, Hanni C, et al. Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 1997; 94: 6803-8.
16. Kostrouch Z, Kostrouchova M, Love W, Jannini E, Piatigorsky J, Rall JE. Retinoic acid X receptor in the diploblast, Tripedalia cystophora. Proc Natl Acad Sci USA 1998; 95: 13442-7.
17. Guo X, Xu Q, Harmon MA, Jin X, et al. Isolation of two functional retinoid X receptor subtypes from the Ixodid tick, Amblyomma americanum (L.). Mol Cell Endocrinol 1998; 139: 45-60.
18. Oro AE, McKeown M, Evans RM. Relationship between the product of the Drosophila ultraspiracle locus and the vertebrate retinoid X receptor. Nature 1990; 347: 298-301.
19. Henrich VC, Sliter TJ, Lubahn DB, MacIntyre A, Gilbert LI. A steroid/thyroid hormone receptor superfamily member in Drosophila melanogaster that shares extensive sequence similarity with a mammalian homologue. Nucleic Acids Res 1990; 18: 4143-8.
20. Billas IM, Moulinier L, Rochel N, Moras D. Crystal structure of the ligand binding domain of the ultraspiracle protein USP, the ortholog of RXRs in insects. J Biol Chem 2000.
21. Hayward DC, Bastiani MJ, Trueman JW, Truman JW, Riddiford LM, Ball EE. The sequence of Locusta RXR, homologous to Drosophila ultraspiracle, and its evolutionary implications. Dev Genes Evol 1999; 209: 564-71.
22. Egea PF, Klaholz BP, Moras D. Ligand-protein interactions in nuclear receptors of hormones. FEBS Lett 2000; 476: 62-7.
23. Wurtz JM, Bourguet W, Renaud JP, et al. A canonical structure for the ligand-binding domain of nuclear receptors [see comments] [published erratum appears in Nat Struct Biol 1996; 3: 206]. Nat Struct Biol 1996; 3: 87-94.
24. Gampe RT, Jr., Montana VG, Lambert MH, et al. Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 2000; 5: 545-55.
25. Egea PF, Mitschler A, Rochel N, Ruff M, Chambon P, Moras D. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. Embo J 2000; 19: 2592-601.
26. Bourguet W, Vivat V, Wurtz JM, Chambon P, Gronemeyer H, Moras D. Crystal structure of a heterodimeric complex of RAR and RXR ligand- binding domains. Mol Cell 2000; 5: 289-98.
27. Gampe RT, Jr., Montana VG, Lambert MH, Wisely GB, Milburn MV, Xu HE. Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. Genes Dev 2000; 14: 2229-41.
28. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. J Mol Biol 2001; 307: 557-76.
29. Kersten S, Kelleher D, Chambon P, Gronemeyer H, Noy N. Retinoid X receptor alpha forms tetramers in solution. Proc Natl Acad Sci USA 1995; 92: 8645-9.
30. Kersten S, Gronemeyer H, Noy N. The DNA binding pattern of the retinoid X receptor is regulated by ligand-dependent modulation of its oligomeric state. J Biol Chem 1997; 272: 12771-7.
31. Kersten S, Dong D, Lee W, Reczek PR, Noy N. Auto-silencing by the retinoid X receptor. J Mol Biol 1998; 284: 21-32.
32. Egea PF, Mitschler A, Moras D. Molecular recognition of agonist ligands by RXRs. Mol Endocrinol 2002; 16: 987-97.
33. Schulman IG, Li C, Schwabe JW, Evans RM. The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. Genes Dev 1997; 11: 299-308.
34. Westin S, Rosenfeld MG, Glass CK. Nuclear receptor coactivators. Adv Pharmacol 2000; 47: 89-112.
35. Westin S, Kurokawa R, Nolte RT, et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators. Nature 1998; 395: 199-202.
36. Perissi V, Staszewski LM, McInerney EM, et al. Molecular determinants of nuclear receptor-corepressor interaction. Genes Dev 1999; 13: 3198-208.
37. DiRenzo J, Soderstrom M, Kurokawa R, et al. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. Mol Cell Biol 1997; 17: 2166-76.
38. Willy PJ, Mangelsdorf DJ. Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. Genes Dev 1997; 11: 289-98.
39. Vivat V, Zechel C, Wurtz JM, et al. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers. Embo J 1997; 16: 5697-709.
40. Zhang J, Hu X, Lazar MA. A novel role for helix 12 of retinoid X receptor in regulating repression. Mol Cell Biol 1999; 19: 6448-57.
41. Nomura Y, Nagaya T, Hayashi Y, Kambe F, Seo H. 9-cis-retinoic acid decreases the level of its cognate receptor, retinoid X receptor, through acceleration of the turnover. Biochem Biophys Res Commun 1999; 260: 729-33.
42. Kopf E, Plassat JL, Vivat V, de The H, Chambon P, Rochette-Egly C. Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway [In Process Citation]. J Biol Chem 2000; 275: 33280-8.
43. Nagaya T, Murata Y, Yamaguchi S, et al. Intracellular proteolytic cleavage of 9-cis-retinoic acid receptor alpha by cathepsin L-type protease is a potential mechanism for modulating thyroid hormone action. J Biol Chem 1998; 273: 33166-73.
44. Mangelsdorf DJ, Umesono K, Evans RM. The retinoid receptors. In: Sporn MB, Roberts AB, Goodman DS, eds. The retinoids (Second ed). New York: Raven Press; 1994: 319-50.
45. Mangelsdorf DJ, Borgmeyer U, Heyman RA, et al. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev 1992; 6: 329-44.
46. Kastner P, Grondona JM, Mark M, et al. Genetic analysis of RXR alpha developmental function: convergence of RXR and RAR signaling pathways in heart and eye morphogenesis. Cell 1994; 78: 987-1003.
47. Sucov HM, Dyson E, Gumeringer CL, Price J, Chien KR, Evans RM. RXR alpha mutant mice establish a genetic basis for vitamin A signaling in heart morphogenesis. Genes Dev 1994; 8: 1007-18.
48. Kastner P, Messaddeq N, Mark M, et al. Vitamin A deficiency and mutations of RXRalpha, RXRbeta and RARalpha lead to early differentiation of embryonic ventricular cardiomyocytes. Development 1997; 124: 4749-58.
49. Chen J, Kubalak SW, Chien KR. Ventricular muscle-restricted targeting of the RXRalpha gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 1998; 125: 1943-9.
50. Tran CM, Sucov HM. The RXRalpha gene functions in a non-cell-autonomous manner during mouse cardiac morphogenesis. Development 1998; 125: 1951-6.
51. Subbarayan V, Mark M, Messadeq N, Rustin P, Chambon P, Kastner P. RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses. J Clin Invest 2000; 105: 387-94.
52. Sapin V, Dolle P, Hindelang C, Kastner P, Chambon P. Defects of the chorioallantoic placenta in mouse RXRalpha null fetuses. Dev Biol 1997; 191: 29-41.
53. Barak Y, Nelson MC, Ong ES, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999; 4: 585-95.
54. Lohnes D, Kastner P, Dierich A, Mark M, LeMeur M, Chambon P. Function of retinoic acid receptor gamma in the mouse. Cell 1993; 73: 643-58.
55. Lohnes D, Mark M, Mendelsohn C, et al. Function of the retinoic acid receptors (RARs) during development (I). Craniofacial and skeletal abnormalities in RAR double mutants. Development 1994; 120: 2723-48.
56. Sucov HM, Izpisua-Belmonte JC, Ganan Y, Evans RM. Mouse embryos lacking RXR alpha are resistant to retinoic-acid-induced limb defects. Development 1995; 121: 3997-4003.
57. Nugent P, Sucov HM, Pisano MM, Greene RM. The role of RXR-alpha in retinoic acid-induced cleft palate as assessed with the RXR-alpha knockout mouse. Int J Dev Biol 1999; 43: 567-70.
58. Imai T, Jiang M, Chambon P, Metzger D. Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytes. Proc Natl Acad Sci USA 2001; 98: 224-8.
59. Rosen ED, Sarraf P, Troy AE, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999; 4: 611-7.
60. Kubota N, Terauchi Y, Miki H, et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999; 4: 597-609.
61. Li M, Indra AK, Warot X, et al. Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature 2000; 407: 633-6.
62. Li M, Chiba H, Warot X, et al. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001; 128: 675-88.
63. Wan YJ, An D, Cai Y, et al. Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver. Mol Cell Biol 2000; 20: 4436-44.
64. Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Sucov HM. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J Biol Chem 2000; 275: 28285-90.
65. Imai T, Jiang M, Kastner P, Chambon P, Metzger D. Selective ablation of retinoid X receptor alpha in hepatocytes impairs their lifespan and regenerative capacity. Proc Natl Acad Sci USA 2001; 98: 4581-6.
66. Huang J, Powell WC, Khodavirdi AC, et al. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res 2002; 62: 4812-9.
67. Kastner P, Mark M, Leid M, et al. Abnormal spermatogenesis in RXR beta mutant mice. Genes Dev 1996; 10: 80-92.
68. Krezel W, Dupe V, Mark M, Dierich A, Kastner P, Chambon P. RXR gamma null mice are apparently normal and compound RXR alpha +/-/RXR beta -/-/RXR gamma -/- mutant mice are viable. Proc Natl Acad Sci USA 1996; 93: 9010-4.
69. Mark M, Ghyselinck NB, Wendling O, et al. A genetic dissection of the retinoid signalling pathway in the mouse. Proc Nutr Soc 1999; 58: 609-13.
70. Brown NS, Smart A, Sharma V, et al. Thyroid hormone resistance and increased metabolic rate in the RXRgamma-deficient mouse. J Clin Invest 2000; 106: 73-9.
71. Chiang MY, Misner D, Kempermann G, et al. An essential role for retinoid receptors RARbeta and RXRgamma in long-term potentiation and depression. Neuron 1998; 21: 1353-61.
72. Krezel W, Ghyselinck N, Samad TA, et al. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 1998; 279: 863-7.
73. Mascrez B, Mark M, Dierich A, Ghyselinck NB, Kastner P, Chambon P. The RXRalpha ligand-dependent activation function 2 (AF-2) is important for mouse development. Development 1998; 125: 4691-707.
74. Tarrade A, Schoonjans K, Pavan L, et al. PPARgamma /RXRalpha heterodimers control human trophoblast invasion. J Clin Endocrinol Metab 2001; 86: 5017-24.
75. Tarrade A, Schoonjans K, Guibourdenche J, et al. PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation. Endocrinology 2001; 142: 4504-14.
76. Solomin L, Johansson CB, Zetterstrom RH, et al. Retinoid-X receptor signalling in the developing spinal cord. Nature 1998; 395: 398-402.
77. Picard F, Auwerx J. PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002; 22: 167-97.
78. Lenhard JM, Lancaster ME, Paulik MA, et al. The RXR agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic, mice suffering from pancreatic beta-cell dysfunction. Diabetologia 1999; 42: 545-54.
79. Davies PJ, Berry SA, Shipley GL, et al. Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity. Mol Pharmacol 2001; 59: 170-6.
80. Singh Ahuja H, Liu S, Crombie DL, et al. Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol 2001; 59: 765-73.
81. Hallakou S, Doare L, Foufelle F, et al. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 1997; 46: 1393-9.
82. Glazier AM, Scott J, Aitman TJ. Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm Genome 2002; 13: 108-13.
83. Montell E, Turini M, Marotta M, et al. DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 2001; 280: E229-37.
84. Miller VA, Benedetti FM, Rigas JR, et al. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol 1997; 15: 790-5.
85. Lu TT, Repa JJ, Mangelsdorf DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 2001; 276: 37735-8.
86. Repa JJ, Turley SD, Lobaccaro JA, et al. Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 2000; 289: 1524-9.
87. Lu TT, Makishima M, Repa JJ, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell 2000; 6: 507-15.
88. Langmann T, Klucken J, Reil M, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257: 29-33.
89. Ricote M, Huang J, Fajas L, et al. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci USA 1998; 95: 7614-9.
90. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998; 93: 241-52.
91. Stein O, Ben-Naim M, Dabach Y, Hollander G, Stein Y. Macrophage cholesterol efflux to free apoprotein A-I in C3H and C57BL/6 mice. Biochem Biophys Res Commun 2002; 290:1376-81.
92. Laffitte BA, Repa JJ, Joseph SB, et al. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci USA 2001; 98: 507-12.
93. Claudel T, Leibowitz MD, Fievet C, et al. Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. Proc Natl Acad Sci USA 2001; 98: 2610-5.
94. Sherman SI, Gopal J, Haugen BR, et al. Central hypothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 1999; 340: 1075-9.
95. Liu S, Ogilvie KM, Klausing K, et al. Mechanism of selective retinoid X receptor agonist-induced hypothyroidism in the rat. Endocrinology 2002; 143: 2880-5.
96. Brown NS, Smart A, Sharma V, et al. Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse. J Clin Invest 2000; 106: 73-9.
97. Collins SJ. The role of retinoids and retinoic acid receptors in normal hematopoiesis. Leukemia 2002; 16: 1896-905.
98. Defacque H, Commes T, Legouffe E, et al. Expression of retinoid X receptor alpha is increased upon monocytic cell differentiation. Biochem Biophys Res Commun 1996; 220: 315-22.
99. Duprez E, Lillehaug JR, Gaub MP, Lanotte M. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells. Oncogene 1996; 12: 2443-50.
100. Nagy L, Thomazy VA, Heyman RA, Davies PJ. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 1998; 5: 11-9.
101. Lehmann S, Paul C, Torma H. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells. Clin Cancer Res 2001; 7: 367-73.
102. Sunaga S, Maki K, Lagasse E, et al. Myeloid differentiation is impaired in transgenic mice with targeted expression of a dominant negative form of retinoid X receptor beta. Br J Haematol 1997; 96: 19-30.
103. Mehta K, McQueen T, Neamati N, Collins S, Andreeff M. Activation of retinoid receptors RAR alpha and RXR alpha induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Differ 1996; 7: 179-86.
104. Shiohara M, Dawson MI, Hobbs PD, et al. Effects of novel RAR- and RXR-selective retinoids on myeloid leukemic proliferation and differentiation in vitro. Blood 1999; 93: 2057-66.
105. Nagy L, Thomázy VA, Shipley GL, et al. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 1995; 15: 3540-51.
106. Nagy L, Thomázy VA, Chandraratna RA, Heyman RA, Davies PJ. Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leuk Res 1996; 20: 499-505.
107. Benoit GR, Flexor M, Besancon F, et al. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells. Mol Endocrinol 2001; 15: 1154-69.
108. Johnson BS, Chandraratna RA, Heyman RA, Allegretto EA, Mueller L, Collins SJ. Retinoid X receptor (RXR) agonist-induced activation of dominant- negative RXR-retinoic acid receptor alpha403 heterodimers; is developmentally regulated during myeloid differentiation. Mol Cell Biol 1999; 19: 3372-82.
109. Benoit G, Altucci L, Flexor M, Ruchaud S, Lillehaug J, Raffelsberger W, Gronemeyer H, Lanotte M. RAR-independent RXR signaling induces t(15;17) leukemia cell maturation. Embo J 1999; 18: 7011-8.
110. Altucci L, Gronemeyer H. Decryption of the retinoid death code in leukemia. J Clin Immunol 2002; 22: 117-23.